19 小时
来自MSNOrthofix (OFIX) Q4 Earnings Lag EstimatesOrthofix (OFIX) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.10 per share a year ago. These figures are ...
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that Nestor ...
An announcement from Nuwellis ( ($NUWE) ) is now available. On February 24, 2025, Nuwellis, Inc. announced the retirement of Nestor Jaramillo, Jr.
Nuwellis (NUWE) announced that Nestor Jaramillo retired as president and CEO and as a director of the company, effective February 18. John Erb, ...
A Meta-Analysis of 22 Studies, and Data from the IRIS® Registry Highlighting Clinical Outcomes in Real-World Clinical ...
公司董事会主席John Erb已接任临时总裁兼CEO职务。Erb在这一职位上拥有丰富经验,他曾于2015年11月至2021年1月期间担任Nuwellis的总裁兼CEO。他与公司的渊源可追溯至2012年9月成为董事,并于同年10月担任董事长。根据InvestingPro分析,尽管公司当前比率保持在2.03的稳健水平,但现金消耗速度较快,此时的领导层交接显得尤为关键。
John Erb, Current Chair of the Board, Appointed Interim President and CEOMINNEAPOLIS, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on ...
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® ...
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% reductio ...
BATON ROUGE, La., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) today announced that Sean Reilly, CEO of Lamar Advertising Company, is scheduled to participate in a ...
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from ...
Furthermore, SeaStar Medical has settled a dispute with Nuwellis over a distribution agreement for its pediatric SCD product, agreeing to pay Nuwellis $900,000. Finally, the company has seen ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果